New Anvita Product Leverages Comparative Effectiveness Research for Drug Selection | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

New Anvita Product Leverages Comparative Effectiveness Research for Drug Selection

November 5, 2010
by root
| Reprints

With its third patent this year, San Diego-based clinical analytics provider Anvita Health has generated another point-of-care innovation with a method for using electronic medical record data combined with comparative effectiveness and formulary plan data to generate a highly personalized drug therapy regimen.

The patent, issued earlier this month, uses a computerized indexing system integrating several databases to rank and sort available drugs to treat a given diagnosis. Ranking and sorting the drugs is conducted within the context of an individual patient’s medical history based upon data extracted from medical claims, pharmacy claims, lab values, electronic medical records, and any other available clinical data.

Using evidence-based rules, including rules based upon the findings of Patient-Centered Outcomes Research, also known as comparative effectiveness research, total efficacy of drug regimens is analyzed, and the results may be output or displayed in a variety of ways for use by the health care provider.


The Health IT Summits gather 250+ healthcare leaders in cities across the U.S. to present important new insights, collaborate on ideas, and to have a little fun - Find a Summit Near You!


/news-item/new-anvita-product-leverages-comparative-effectiveness-research-drug-selection

See more on

betebettipobetngsbahis